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Abstract.
Background: Huntington’s disease (HD) is a rare, incurable neurodegenerative disorder caused by a CAG trinucleotide
expansion with the first exon of the huntingtin gene. Numerous knock-in mouse models are currently available for modelling
HD. However, before their use in scientific research, these models must be characterised to determine their face and predictive
validity as models of the disease and their reliability in recapitulating HD symptoms.
Objective: Manifest HD is currently diagnosed upon the onset of motor symptoms, thus we sought to longitudinally
characterise the progression and severity of motor signs in the HdhQ111 knock-in mouse model of HD, in heterozygous
mice.
Methods: An extensive battery of motor tests including: rotarod, inverted lid test, balance beam, spontaneous locomotor
activity and gait analysis were applied longitudinally to a cohort of HdhQ111 heterozygous mice in order to progressively
assess motor function.
Results: A progressive failure to gain body weight was demonstrated from 11 months of age and motor problems in all
measures of balance beam performance were shown in HdhQ111 heterozygous animals in comparison to wild type control
animals from 9 months of age. A decreased latency to fall from the rotarod was demonstrated in HdhQ111 heterozygous
animals in comparison to wild type animals, although this was not progressive with time. No genotype specific differences
were demonstrated in any of the other motor tests included in the test battery.
Conclusions: The HdhQ111 heterozygous mouse demonstrates a subtle and progressive motor phenotype that begins at 9
months of age. This mouse model represents an early disease stage and would be ideal for testing therapeutic strategies that
require elongated lead-in times, such as viral gene therapies or striatal transplantation.
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INTRODUCTION
The presentation of overt motor symptoms, has
been shown to occur in the disease progression of
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Huntington’s disease (HD) in both the human condi-
tion [1, 2] and in knock-in mouse models of HD [3–7].
Typically, a clinical diagnosis of manifest HD is based
on the total motor score (TMS) of the Unified Hunt-
ington’s Disease Rating Scale (UHDRS). Therefore,
in order to determine whether the HdhQ111 mouse
model accurately reflects the human condition of HD
in terms of face, construct and predictable valid-
ity, it is important to determine if and when motor
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signs develop and the severity of these signs. In the
present study, heterozygous animals (with one mutant
allele, as in most HD patients) were studied in an
attempt to appropriately model the human condition
of HD.
A behavioural test battery of motor function was
applied longitudinally to determine the time course
of motor sign development and progression in the
HdhQ111 mouse model of HD. The accelerating
rotarod was used to assess motor co-ordination, as
it has previously been used extensively to clas-
sify motor dysfunction in a range of HD mouse
lines [3–12]. A balance beam apparatus was used to
determine abnormalities in co-ordinated movement
and balance, which have been demonstrated in HD
patients [13] and mouse models [5, 11, 14]. In addi-
tion, a further test of motor function using an inverted
grid was used, as this has been used previously to
determine motor function in HD mice [5, 11, 15].
Spontaneous locomotor activity testing was included
in the motor test battery to investigate changes in
both general locomotor activity levels and disruption
to circadian rhythms which manifest as sleep distur-
bances in HD patients [16–18] and which have also
been described in HD mouse lines [2, 15, 19–21]. Gait
abnormalities have also been shown in HD patients
[22–27] and HD mouse lines [28–30], including the
HdhQ111 mouse model [15, 29, 30], thus gait analy-
sis was also included in the longitudinal motor test
battery.
In addition to overt motor symptoms, weight loss
is common in HD patients [31–33], even in the early
stages of the disease [34]. Decreases in body weight
as HD progresses have been described in a range
of both transgenic and knock-in mouse models [5,
11, 19], including the HdhQ111 mouse line [29, 35].
However, full length human HTT transgenic mice,
including BACHD and YAC transgenic mouse lines
demonstrate an increase in body weight during HD
disease progression [36, 37]. Therefore, it was neces-
sary to determine the body weight progression of the
HdhQ111 heterozygous animals to compare and con-
trast any weight changes seen, to further determine
how accurately the HdhQ111 mouse model reflects
the human condition. Furthermore, body weight was
used to determine the health and wellbeing of ani-
mals, 20% weight loss was used to define a humane
endpoint in experimental procedures.
Behavioural analyses in heterozygous mice are
vital to understand the phenotype observed and the
relevance to the human condition of HD. Several
behavioural analyses of knock-in mouse models
have demonstrated subtle behavioural phenotypes
[12, 29, 38] which often lack the severe symptoms
demonstrated in late stage human patients. A broad
and extensive phenotypic screen has been previ-
ously described for HdhQ111 heterozygous mice [29],
although this study only characterised animals until
46 weeks of age. Thus, in the present study we sought
to extend, develop and verify previous behavioural
findings observed in HdhQ111 heterozygous mice
by completing a longitudinal motor characterisation
over 18 months.
A vast number of mouse models of HD are now
available for scientific research means, but before
their use, each mouse model must be characterised
to determine their suitability in accurately recapitu-
lating the behavioural symptoms of HD. We therefore
sought to longitudinally characterise the progression
of motor deficits in the HdhQ111 heterozygous knock-
in mouse model of HD.
MATERIALS AND METHODS
Animals
HdhQ111 knock-in mice (Jax®, Bar Harbour,
Maine, U.S.A.) were bred inhouse on a C57BL/6J
background. A total of 56 age matched mice were
used (36 HdhQ111/+ animals, with a CAG repeat
length range 131–143 and an average of 138 CAG
repeats). Of these HdhQ111/+ mice 16 were male and
20 were female. Of the 20 wild type mice 10 were
male. Animals were housed in mixed genotype pairs
or threes, although some animals had to be separated
and singly housed to prevent fighting. Each cage con-
tained modest environmental enrichment of a single
cardboard tube and a wooden chew stick. Testing
occurred during the light phase from 12.00 hours to
18.00 hours. A female HdhQ111/+ animal was culled
at 12 months of age, and 2 male animals (one wild
type and one HdhQ111/+) were culled at 16 months
of age due to health issues unrelated to HD. Experi-
ments were conducted in accordance with the United
Kingdom Animals Scientific Procedures Act (ASPA)
1986. From 1st January 2013, the European Union
(E.U.) Directive 2010/63/EU was implemented into
UK law by an update of ASPA 1986.
Genotyping
Upon weaning, all HdhQ111 animals were tail
tipped for genotyping purposes. Ethyl chloride anaes-
thetic spray (Vidant Pharma Ltd, Surrey, U.K.) was
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Fig. 1. Longitudinal hand testing time scale. Animals were tested in the longitudinal motor test battery every 3 months. Rotarod, balance
beam, inverted grid and locomotor activity testing occurred every 3 months, from 3 months of age until 18 months of age. Additional tests
of gait analysis were completed at the 6 month, 12 month and 18 month time points.
applied to the tip of the tail before removing a 1 mm
section. The tail was then cauterised with a silver
nitrate pen and samples were collected in Eppen-
dorf tubes. All samples were then shipped on dry
ice to Laragen Inc. (Culver City, California, U.S.A).
All genotyping was performed by Laragen Inc. using
probe based qPCR to generate the genotype of the ani-
mal and corresponding end-point PCR to determine
CAG repeat length.
Behavioural methods
Animals were tested at three month intervals in
a behavioural test battery that included: locomotor
activity, rotarod, inverted grid and balance beam. In
addition, at six month intervals a test of gait analysis
was added into the test battery, as shown in Fig. 1.
Weight progression
Animals were weighed monthly between 15.00
hours and 16.00 hours. Body weight was also used to
determine the health and wellbeing of animals, 20%
weight loss was used to define a humane endpoint in
experimental procedures.
Rotarod
Animals received 5 days of training on a rotarod
apparatus (Ugo Basile, Model Number 47600,
Varese, Italy). Day 1 consisted of training with the
rod accelerating from 5 revolutions per minute (rpm)
to 24 rpm. Training days 2 to 5 consisted of training
with the rod accelerating from 5 rpm to 44 rpm. Dur-
ing the training period animals were put back onto
the accelerating rod if they fell from the apparatus.
Training sessions lasted a maximum of 300 seconds
(5 minutes) each and were completed on consecu-
tive days. Animals were then tested on the apparatus
which consisted of 2 trials (accelerating from 5 rpm
to 44 rpm in a single session). The latency to fall from
the rod was recorded for each trial following the acti-
vation of a button situated below the rotarod. The
values from both trials were averaged to provide the
rotarod latency statistic. If the mouse remained on the
accelerating beam for whole 5 minute testing period,
they were removed at the end of the testing session
and given a score of 300 seconds.
Inverted grid test
Animals were placed on a mesh grid (30 cm ×
30 cm) which had a wooden border. For testing,
towels were placed under the apparatus to provide
a comfortable landing surface. The grid was then
inverted 30 cm above the bench by placing 4 wooden
posts under the border of the grid, such that the mouse
was suspended upside down on the under surface.
Latency to fall from the grid was recorded; the max-
imum time allowed per trial was 60 seconds.
Balance beam
Animals were initially trained on the apparatus
(1 m in length, 17º angle of ascent, with a 1.5 cm to
0.5 cm taper across the width) to encourage travers-
ing of the beam to the ‘house’ box located at the high
end. Training day 1 consisted of placing the mouse on
the beam initially close to the ‘house’ box and then
increasing the distances away from the ‘house box’
until the animal was at the start area of the beam.
The mouse was then placed facing away from the
‘house’ box at the end of the beam (to allow turn
time to be measured as a measure of motor coor-
dination) and encouraged to turn around and fully
traverse the beam. The second day of training con-
sisted of 2 trials where the animal was placed facing
away from the ‘house’ box and needed to turn around
and traverse the beam to enter the ‘house’ box at the
top. Testing was conducted by 2 consecutive trials
which were videotaped to enable analysis. The ani-
mal was placed at the far end of the balance beam
facing away from the ‘house’ box; the time taken
to turn around and the time taken to traverse the
beam were recorded. Between each trial mice were
given 1 hour to recover before the next trial. While
traversing the beam foot slips for the front and hind
legs on each side were recorded, one side was live
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Fig. 2. Gait analysis apparatus and representative images of the results obtained. A. A photograph of the gait corridor apparatus used in gait
analysis. B. Representative image of the results obtained from gait analysis. C. Schematic illustration of gait analysis measurements of stride
length, stride width and stride overlap.
scored and the other video recorded to allow bilateral
analysis.
Spontaneous automated locomotor activity
Animals were placed in a clear Perspex cage
(dimensions 40 cm × 24 cm × 18 cm) on a metal rack
through which 3 infrared beams were able to pass,
crossing the base of each cage. Locomotor activity
was recorded, via non-perseverative infrared beam
breaks (beam breaks in duration of less than 3 sec-
onds), for a total of 32 hours on MED-PC® (version 4)
software (Vermont, USA) to determine changes cir-
cadian cycle mediated activity levels. Animals were
allowed ad-libitum access to both food and water
which were placed at opposite ends of the clear Per-
spex cage. Lamps were placed into the testing room
and set on a timer to ensure that animals were main-
tained on their standard 12 hour light/dark cycle,
lights on at 06.00 hours and lights off at 18.00 hours.
Gait analysis
Measurement of gait analysis was conducted
using a clear Perspex corridor apparatus (65 cm ×
5 cm × 15 cm), as previously described [19] and
shown in Fig. 2A, which was lined with a pre-cut
piece of white paper. Animals were trained to run to
the enclosed darkened box at the end of the corridor
by placing the mouse at the far end of the corridor
and encouraging them to move towards the goal box
at the end. Training was conducted twice for each
mouse until the animal readily ran to the end box
without encouragement. For testing, the paws of the
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Fig. 3. Weight progression of HdhQ111/+ animals over 18 months. Mice were weighed at 2 months of age and subsequently every month. The
data represents the mean weight of HdhQ111/+ and wild type animals averaged to provide the data point. Data was analysed using a repeated
measures ANOVA. The data represents a total of 36 HdhQ111/+ animals, of which 16 were male and 20 wild type animals, of which 10 were
male. Error bars represent standard error of the mean. Significant differences are stated for males and females combined. Asterisks represent
the significance level for a genotype comparison at a particular age after multiple testing correction ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
animal were painted with non-toxic paint (TTS paint,
Nottinghamshire, UK); red was used for the front
paws and blue for the hind paws. The animal was
then placed at the near end of the apparatus and ran
to the enclosed goal box at the far end of the appa-
ratus, leaving a print of the associated foot prints on
the paper at the base of the apparatus (Fig. 2B). The
mouse was then placed into a water bath to wash
and groom before being returned to the home cage.
The paper print was then allowed to air dry to enable
analysis of; stride length, width and overlap for both
the front and hind paws of each animal. For each
animal, this was calculated using 4 paw prints, this
allowed 3 values to be calculated for each measure-
ment (stride length, stride width and overlap) which
were then averaged to provide gait measurements
(Fig. 2C).
Statistical analysis
Statistical analyses were conducted in IBM SPSS
20 Statistics Software. Typically, three way split
plot analyses with ANOVA were used with repeated
measures of age and between subject measures of
genotype and sex, followed by simple effects anal-
ysis. Where significance was found post-hoc tests
with Bonferroni corrections were performed. In the
cases where missing values were present, due to ani-
mals needing to be culled for health reasons, missing
data were estimated by an unbiased iterative inter-
polation procedure within the IBM SPSS statistical
analysis.
RESULTS
Weight progression results
Male animals were significantly heavier than their
female counterparts throughout the 18 months of test-
ing (Fig. 3: Sex; F1,52 = 248.05, p < 0.001). Wild type
and HdhQ111/+ animals demonstrated similar body
weights at the earlier testing time points, however
HdhQ111/+ animals subsequently failed to gain body
weight in comparison to their wild type littermates,
as demonstrated by the divergence of the wild type
andHdhQ111/+ weight curves for both sexes similarly
(Fig. 3: Age × Genotype; F16,832 = 6.98, p < 0.001).
Post-hoc tests confirmed that the significant differ-
ence in body weight began at 11 months of age
(p = 0.038) (as shown in Fig. 3).
Spontaneous automated locomotor
activity results
Spontaneous locomotor activity was tested lon-
gitudinally in HdhQ111/+ animals (Fig. 4). No
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Fig. 4. Spontaneous locomotor activity longitudinal results for HdhQ111/+ animals over 18 months. Results are shown over 24 hours (from
15.00 hours to 15.00 hours) at each time point. The data represents a total of 36 HdhQ111/+ animals, of which 16 were male and 20 wild type
animals, of which 10 were male. A main effect of time was demonstrated at each age, with animals generally more active in the dark phase
(18.00 hours to 06.00 hours). No significant differences were demonstrated between genotypes at any age. No significant sex differences
were demonstrated thus data for males and females was combined. Error bars represent standard error of the mean.
significant differences were observed in the total non-
perseverative beam breaks between HdhQ111/+ and
wild type animals, at any age tested. However, ani-
mals displayed decreased levels of locomotor activity
as they aged (Fig. 4: Age; F5,255 = 24.42, p < 0.001).
Furthermore, a significant effect of time of day was
observed (Fig. 3: Time; F24,1224 = 116.65, p < 0.001),
with animals generally becoming more active in
the dark phase (18.00 hours to 06.00 hours) than
in the light phase. However no significant differ-
ences were observed in locomotor activity between
HdhQ111/+ and wild type animals (Fig. 4: Genotype;
F1,52 = 0.002, p = n.s.).
Inverted grid test results
HdhQ111/+ animals displayed no impairments in
the inverted grid test, in comparison to wild type
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Fig. 5. Inverted grid test results forHdhQ111/+ animals over 18 months. Mice were tested at 3 months of age and subsequently every month. The
average latency to fall represents an average of 2 trials for HdhQ111/+ and wild type animals at each time point. The data represents a total of 36
HdhQ111/+ animals, of which 16 were male and 20 wild type animals, of which 10 were male. Error bars represent standard error of the mean.
animals at any of the time points tested (Fig. 5:
Genotype; F1,52 = 1.39, p = n.s.). As animals aged
their performance on the inverted grid test decreased
(Fig. 5: Age; F5,260 = 3.83, p = 0.002). Interestingly,
overall, male animals performed significantly worse
on the inverted grid test than female animals (Sex;
F1,52 = 6.68, p = 0.013).
Rotarod results
Rotarod performance considered over the 18
months of testing demonstrated that HdhQ111/+ ani-
mals displayed a decreased latency to fall from the
rotarod in comparison to wild type animals (Fig. 6:
Genotype; F1,52 = 5.83, p < 0.05). A highly signifi-
cant effect of age was seen, with animals displaying a
decreased latency to fall from the rotarod as they aged
(Fig. 6: Age; F5,260 = 15.98, p < 0.001). There was
a trend for HdhQ111/+ animals to have a decreased
latency to fall from the rotarod as they aged, at 12
months, 15 months and 18 months of age in compari-
son to wild type animals, but this effect failed to meet
significance (Fig. 6: Age × Genotype; F5,260 = 1.35,
p = n.s.). Interestingly male animals performed sig-
nificantly worse than female animals throughout
rotarod testing (Sex; F1,52 = 10.46, p < 0.01).
Balance beam results
HdhQ111/+ animals were significantly impaired in
all measures of balance beam performance in com-
parison to wild type animals. Latency to turn on
the balance beam was progressively slower as ani-
mals aged (Fig. 7A: Age; F5,260 = 13.82, p < 0.001).
Although HdhQ111/+ animals did not differ from
wild type animals at younger ages, they were pro-
gressively slower to turn than wild type controls
from 9 months of age (Fig. 7A: Age × Genotype;
F5,260 = 3.376, p < 0.01). Interestingly, female ani-
mals were shown to turn on the beam significantly
faster than male animals (Sex; F1,52 = 5.40, p < 0.05).
Male animals were slower to traverse the bal-
ance beam than female animals (Sex; F1,52 = 13.78,
p < 0.001). Although HdhQ111/+ animals did not
differ in traverse time from wild type animals at
the earliest ages, they were progressively slower to
traverse the balance beam than wild type animals
(Fig. 7B: Age × Genotype; F1,52 = 15.29, p < 0.001).
Measurement of foot slips made while traversing
the balance beam demonstrated that the number of
foot slips made by HdhQ111/+ animals did not differ
from wild type animals at younger ages. However,
HdhQ111/+ animals made progressively more foot
slips than wild type animals from 12 months of age
(Fig. 7C: Age × Genotype; F5,260 = 40.56,p < 0.001).
Gait analysis results
HdhQ111/+ animals did not show any impairments
in gait in comparison to wild type animals in stride
length (Fig. 8A: Genotype; F1,52 = 0.04, p = n.s.),
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Fig. 6. Rotarod performance in HdhQ111/+ animals over 18 months. The data represents a total of 36 HdhQ111/+ animals, of which 16 were
male and 20 wild type animals, of which 10 were male. Data is shown as an average of 2 trials. Error bars represent standard error of the
mean.
stride width (Fig. 8B: Genotype; F1,52 = 0.02,p = n.s.)
or stride overlap (Fig. 8C: Genotype; F1,52 = 0.02,
p = n.s.). However, as animals aged, their stride length
decreased (Fig. 8A: Age; F2,104 = 15.37, p < 0.001),
as did their stride overlap (Fig. 8C: Age; F2,104 = 4.36,
p < 0.05). However, no significant effect of age was
seen in stride width (Fig. 8B: Age; F1,52 = 3.61,
p = n.s.).
DISCUSSION
The results of the longitudinal motor charac-
terisation of HdhQ111/+ animals demonstrated that
significant motor deficits occurred in balance beam
performance from 9 months of age in HdhQ111/+
heterozygous animals. Significant deficits in rotarod
performance were observed in HdhQ111/+ heterozy-
gous animals in comparison to wild type animals,
although these were not progressive over time.
HdhQ111/+ heterozygous animals had a significant
inability to gain weight in comparison to wild type
animals from 11 months of age.
The observed weight differences replicate previ-
ous findings in both transgenic and knock-in mouse
models of HD [5, 11, 19], although the progression
and extent of the failure to gain weight or weight loss
observed, varies with each particular mouse model.
The progressive failure to gain weight demonstrated
in HdhQ111/+ animals from 11 months of age may
be reflective of the weight abnormalities shown in
the human condition [31, 32, 34, 39]. However, the
human condition often represents a weight loss rather
than a failure to gain weight. Although the underly-
ing reasons for the inability to gain weight, observed
in this case, are still unknown. The lack of observ-
able chorea in HdhQ111/+ mice, despite an inability
to gain weight, may lead to the conclusion that an
underlying metabolic problem in the cause. This sug-
gestion has been explored in HD patients [40–42] and
in other mouse strains [43–46], although, it is yet to
be explored in the HdhQ111 mouse model of HD.
The results obtained on several of the motor tests
can be sensitive to the confounding effects of body
weight. The significant difference between the weight
of male and female animals may explain some of
the sex differences observed in the motor tests, as
some of the motor tests such as the rotarod and
inverted grid test are sensitive to the effects of gravity.
Furthermore, significant sex differences and interac-
tions between sex and genotype were inconsistently
produced throughout the longitudinal motor char-
acterisation. The effect, if any, which the weight
changes had on the motor read outs for the genotypes
presented here, is uncertain. Although, if weight were
to influence the motor results obtained for genotype,
it may be that heavier animals, in this case the wild
type animals, are likely to be disadvantaged in tasks
such as the rotarod in comparison to their HdhQ111/+
littermates, which is not demonstrated in the results.
It could also be argued that a decreased body weight
may be advantageous in other motor tests such as
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Fig. 7. Balance beam performance in HdhQ111/+ animals over 18 months. A. Time to turn on the balance beam demonstrated HdhQ111/+
animals were significantly slower to turn on the beam than wild type animals, from 9 months of age. B. Traverse time on the balance beam
showed HdhQ111/+ animals were significantly slower to traverse the beam than wild type animals from 9 months of age. C. Total number of
foot slips made while crossing the beam demonstrated HdhQ111/+ animals made significantly more foot slips from 12 months of age. The
data represents a total of 36 HdhQ111/+ animals, of which 16 were male and 20 wild type animals, of which 10 were male, sexes shown
separately. Error bars represent standard error of the mean. Asterisks represent the significance level for a genotype comparison at a particular
age after multiple testing corrections ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
the balance beam, although this is not the case in the
results observed.
Significant motor deficits were seen in HdhQ111/+
animals in turn time and traverse time on the bal-
ance beam apparatus from 9 months of age, thus
suggesting an inability to initiate movement and
subsequently move along the beam. Furthermore,
the increased number of foot slips that HdhQ111/+
animals made while crossing the balance beam com-
pared to wild type animals at 12, 15 and 18 months
of age, are indicative of progressive impairments
in motor co-ordination and balance. Sex differences
were demonstrated, with female animals generally
displaying a more rapid time to turn and traverse the
beam, although these differences between sexes were
not consistently produced over time and their level of
significance was not as high as that of the genotype
differences. Problems with balance are particularly
important to consider in people who are affected by
HD, as this can lead to an increased risk of falls
[47], social isolation and thus a reduced quality of
life [48–50].
Further motor deficits were demonstrated in
HdhQ111/+ animals in rotarod performance, as
HdhQ111/+ animals displayed a decreased latency to
fall from the rotarod in comparison to wild type ani-
mals, although this difference was not progressive
over time. These deficits in rotarod performance are
indicative of problems in co-ordinated movement in
HdhQ111/+ animals. Significant gender differences
were observed in rotarod performance, with female
animals performing significantly better on the rotarod
than male animals. These gender differences may be
attributable to differences in weight between male
and female animals. This suggestion has previously
been described in other outbred mouse strains [51].
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Fig. 8. Gait analysis results for HdhQ111/+ animals over 18 months. No significant differences were observed between HdhQ111/+ and
wild type animals in any measure of gait analysis. The data represents a total of 36 HdhQ111/+ animals, of which 16 were male and 20
wild type animals, of which 10 were male. Data was combined for males and females as no significant differences between the sexes were
demonstrated. Error bars represent standard error of the mean.
The results observed in rotarod and balance beam per-
formance reflect previous findings of impaired motor
learning and co-ordination in HdhQ111/+ mice at 46
weeks of age [29].
AlthoughHdhQ111/+ animals displayed significant
deficits in balance beam traverse time from 9 months
of age, no significant deficits were seen in sponta-
neous locomotor activity in HdhQ111/+ animals in
comparison to wild type animals. These results are
in contrast to a previous study which found hypo-
activity in the dark phase in HdhQ111/+ animals in
comparison to wild type animals. Our results may
be explained by the suggestion that when HdhQ111/+
animals are free to move in the locomotor activ-
ity cages no significant differences in activity are
observed. Whereas, when HdhQ111/+ animals are
challenged to traverse a beam they find the task signif-
icantly harder than wild type animals. Furthermore,
due to the study design, habituation effects of repeat-
edly testing the same animals in a battery of motor
tests should also be considered as a possible explana-
tion as to the differences between the present study
and a previous study which found hypo-activity in
HdhQ111/+ mice [29] The lack of significant deficits
in spontaneous locomotor activity, suggest that the
observed deficits in both rotarod and balance beam
may specifically involve motor co-ordination and bal-
ance.
Locomotor activity was studied in the HdhQ111/+
mouse model of HD because significant deficits in
circadian rhythm had been previously demonstrated
in HD patients [16–18, 21]; however, such differ-
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ences were not observed in this case in the HdhQ111/+
mouse model. Overall, animals displayed decreased
activity as they aged, although this may be the result
of the natural aging process it may also be attributable
to habituation effects. As animals were tested in the
motor test battery every 3 months, they were required
to be tested a total of 6 times within the test bat-
tery. Therefore, it could be the case that animals
became increasingly habituated to the locomotor
activity boxes and thus moved less during subsequent
testing. This is suggested in particular by the large
decline in locomotor activity between the first and
second tests, at 3 months of age and 6 months of age
respectively, before other motor deficits were appar-
ent. Furthermore, this suggestion may also be valid
for the other motor tasks, as the same animals were
used repeatedly in the longitudinal testing paradigm,
this meant that animals received repeated testing on
the motor tests at a young age; therefore this exposure
and testing at a young age may well have affected
future motor test read outs. To prevent these types
of habituation or practice effects occurring in future
longitudinal motor characterisations, a new group of
animals could be tested at each time point, although
this would have considerable ethical and financial
implications and could no longer be considered true
longitudinal testing.
The lack of genotype differences in the inverted
grid test is perhaps unsurprising due to the relatively
insensitive nature of the behavioural test, with the
majority of animals performing close to the 60 sec-
ond ceiling in the protocol. The inverted grid test
is highly likely to be influenced by differences in
body weight, with heavier animals falling from the
grid more rapidly than lighter animals. However, if
this were to be the case it is likely to disadvantage
wild type animals rather than HdhQ111/+ animals,
which is not the case in the observed results. Fur-
thermore, the time that each trial was conducted for
(60 seconds) is in accordance with the relevant licenc-
ing requirements to minimise pain, suffering, distress
and lasting harm to animals; however this may not
be long enough to draw out any genotypic differ-
ences. It is plausible that sensitivity to detect genotype
and aging effects may be increased by extending the
test duration to 2 or 3 minutes, but this is yet to be
investigated. Therefore, the inverted grid test used in
this case, may not be an appropriately sensitive test
measure. Attempts to use a mechanical grip strength
metre [52] have been used successfully in observing
deficits in grip strength in other mouse models [53,
54] and in the R6/2 mouse model of HD [55]. There-
fore, in future longitudinal motor characterisations it
may provide more meaningful data if a mechanical
grip strength metre were used in behavioural testing.
No significant gait abnormalities were observed in
HdhQ111/+ animals in the present study, although the
characterisation was only conducted until 18 months
of age, therefore it may be the case that such abnor-
malities would have developed at a later time point.
However, motor abnormalities were demonstrated at
earlier ages and thus for practical, financial and wel-
fare reasons it was pre-planned to end the motor
characterisation at 18 months of age. Our results are
in contrast to others who have found gait abnormali-
ties in the HdhQ111/+ mice at 46 weeks [29], although
in this case the methods used to determine gait per-
formance were automated and thus comparatively
more sophisticated than the methods utilised here. In
another study in both HdhQ111/+ and HdhQ111/Q111
mice, gait abnormalities were found at 24 months of
age [30], utilising a similar method to that employed
here, although these animals were bred on a CD1
background strain, which is different to the back-
ground strain of the animals used in this study. Thus,
the background strain and equipment used for the
gait testing are both likely to impact upon the results
observed.
In some tests (inverted grid, rotarod, balance beam)
motor impairments in HdhQ111/+ animals in compar-
ison to their wild type littermates, were more marked
in male animals than in female animals. The gen-
der differences between male and female animals do
not appear to be stable within the behavioural results
of the motor tests and often there was no interac-
tion between sex and genotype. Therefore, overall
genotypic differences were of primary concern in
determining whether the HdhQ111/+ mice accurately
reflects the motor symptoms of HD. The sex differ-
ences could be attributable weight differences among
the sexes, although it is plausible to use a single sex
of animals in behavioural testing, this has significant
practical, ethical and financial implications and as
HD is a disease which affects both sexes equally, both
sexes were used in behavioural testing to reflect this.
Sex differences have previously been observed in
the HdhQ111 mouse line [29] and male animals have
been shown to demonstrate increased anxiety [35].
Anxiety measurements were not conducted in this
particular study, and it is noteworthy that the literature
regarding anxiety problems in the HdhQ111 mouse
model has shown conflicting results. Decreased anx-
iety has been demonstrated in HdhQ111/+ mice on
a C57BL/6J background strain at 11 weeks of age
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[29]. Whereas, others have shown increased anxiety
in male HdhQ111/+ mice on a CD1 background strain
[35]. Therefore, further studies are required to deter-
mine if the HdhQ111 mouse model of HD reflects any
of the symptoms of anxiety that are shown in the
human condition.
In summary, the longitudinal motor characterisa-
tion presented here, demonstrated a gradual decrease
in the ability of HdhQ111/+ animals to gain weight in
comparison to their wild type littermates. The emer-
gence of motor deficits in rotarod performance in
HdhQ111/+ animals from 12 months of age and in
balance beam performance from 9 months of age
demonstrates subtle and progressive motor deficits
which resemble early stage HD, as the deficits are spe-
cific in nature and lack the gross dyskinesia observed
in late stage HD patients. These findings are crucial
in determining how accurately the HdhQ111 mouse
model of HD reflects motor signs observed in the
human condition.
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